Fingerprinting Biosimilars

Wednesday, August 17, 2016

Location: Agensys, Inc.

1800 Stewart Street, Santa Monica, CA   

Host:    David Steinberg, Director, Engineering & Facilities, Agensys, Inc. 

Program Managers:          Justin Cantor, Director, PSC Biotech

                                             Paul Crissman, Principal, Biotechnical Solutions

Speaker:                              Dr. Fiona Greer, SGS Life Sciences

Schedule: 

5:45 – 6:30 pm      Registration and Networking Reception with Appetizers

6:30 – 7:30 pm      Program

7:30 – 8:00 pm      Q&A and Networking

Synopsis:

Biosimilar development requires initial comprehensive characterization of the target molecule to determine the exact structure, post-translational modifications and variability of quality attributes to establish the Quality Target Product Profile (QTTP). The engineered biosimilar should match this profile.

For regulatory approval, comparative data for the biosimilar side-by-side with the originator is required. Initially this includes both structural and functional activities.

Analytical strategies for primary and higher order structure determination will be discussed particularly for antibodies where their size and complexity requires LC/MS/MS approaches. Appropriate orthogonal analytical techniques which address regulatory requirements for “finger-print like” assessment, both conventional and emerging technologies, will be reviewed.

Speaker Bio:

Dr Fiona Greer was a founding Director of M-Scan (Mass Spectrometry Consultants and Analysts), contract analytical laboratories specializing in  biopharmaceutical characterization. Following acquisition in 2010, she is now Global Director, Biopharma Services Development, SGS Life Sciences.

Following a Ph.D. in Protein Biochemistry from Aberdeen University (1984) she joined M-Scan to establish and direct biologics characterization services. Here, she pioneered and applied new developments in Mass Spectrometry for structural analysis and sequencing of proteins and carbohydrates resulting in numerous publications and patents. She was instrumental in expansion of the group, establishing a US facility where she was appointed VP.

With over 35 years experience in glycoprotein analysis using mass spectrometry and other instrumental techniques, she has been involved with a diverse range of biotechnology products, both novel and biosimilar and consults to companies throughout the world. She is regularly invited to give presentations and workshops at international meetings. In 2016 she was named in the Medicine Makers “Power List – Top 100 influencers”.

Free for Agensys Employees: Please register prior for the event so we have enough food for the group and can prepare name badges.

________$60 ISPE Members

________$85 NonMembers

________$25 Students and Government (and additional Agensys employees)

________$40 ISPE Young Professional (YP) Member

________Free for 1st 15 Agensys Employees

________$500 Event Sponsor: Sponsors receive a 6′ exhibit table and two admissions to the meeting.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: